PlainPharmaWatch

CMS Open Payments · Program Year 2024

Icometrix NV

Icometrix NV reported $67,000.00 in payments to 26 physicians and teaching hospitals across 26 transactions.

See the rankings → How this is sourced
$67.0K
Total payments
26
Transactions
26
Recipients
#1278
of 1,925 companies

Icometrix NV reported $67,000.00 in payments to 26 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1278 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.6K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Icometrix NV pairs below-median payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1278
of 1,925 companies
0.0%
of all US industry payments
0.8%
paid to its single top recipient
1
payment categories

How Icometrix NV ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Icometrix NV's total vs. every reporting company

CMS Open Payments, Program Year 2024

$67,000 34th percentile higher than 34% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Icometrix NV

Rank #1278 of 1,925 companies in CMS Open Payments for 2024 belongs to Icometrix NV, which reported $67,000.00 across 26 transactions to 26 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $2.6K per transaction and $2.6K per recipient.

Of the 1 general-payment categories charted below, "Consulting Fee" is the largest at $67.0K across 26 transactions, 100.0% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Icometrix NV made 1 types of general payments. "Consulting Fee" is the largest category at $67.0K, 100.0% of the company's reported total.

How Icometrix NV divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$67.0K
Payment Type Amount Transactions
Consulting Fee $67.0K 26

Recipient Concentration in General Payments

The five largest recipient relationships account for $67,000.00 (100.0%) of $67,000.00 in this company's General Payments records across 3 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Icometrix NV

The five named recipients with the highest reported General Payments from this company

Lawrence N Tanenbaum$52.0KMax Wintermark$12.0KMartin Niethammer$3.0K
  1. 1

    Lawrence N Tanenbaum

    $52,000.00 across 13 reported transactions

  2. 2

    Max Wintermark

    $12,000.00 across 12 reported transactions

  3. 3

    Martin Niethammer

    $3,000.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $2.6K. Average per recipient: $2.6K.

Total Amount

$67,000.00

Avg per Transaction

$2.6K

Avg per Recipient

$2.6K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Icometrix NV Share

0.0%

#1278 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Icometrix NV

MIM Software Inc.

$67.1K 50 recipients

Momentis Surgical Inc.

$66.7K 21 recipients

Immunitybio, Inc.

$67.8K 1,612 recipients

Shimadzu Precision Instruments, Inc.

$67.9K 21 recipients

Cambridge Interventional LLC

$66.1K 36 recipients

Pathway Medical Partners, LLC

$66.0K 33 recipients

Frequently Asked Questions

How much did Icometrix NV pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Icometrix NV, totaling $67,000.00 across 26 transactions to physicians and hospitals.
How many physicians received payments from Icometrix NV? ▾
Icometrix NV made payments to 26 physicians and teaching hospitals in 2024. The average payment per recipient was $2.6K.
What types of payments did Icometrix NV make? ▾
1 categories of general payment make up Icometrix NV's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $67.0K, representing 100.0% of the company's reported total.
How does Icometrix NV rank among pharmaceutical companies? ▾
Icometrix NV ranks #1278 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Icometrix NV? ▾
In 2024, Icometrix NV averaged $2.6K per transaction across 26 transactions to 26 recipients.
Where does the payment data for Icometrix NV come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Icometrix NV's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.